Key result
Complete guideline adherence post-ACS reaches ~69%, lagging in elderly women and NSTEMI patients.
Cross-Sectional (n=2,471)
Yes
Guideline adherence for secondary prevention medication following acute coronary syndrome was 69.1%, with significant variation between hospitals and lower adherence in patients with NSTEMI/UA, prior CABG, or elderly women.
Answers are grounded in this paper and cite their sources.
Discharge medication review remains essential; observational data leaves open optimal strategies to minimize hospital and subgroup variation.
BACKGROUND: The prescription of guideline-recommended medication for secondary prevention after acute coronary syndrome has been suboptimal in the past. In the present study, guideline adherence and associated patient, care and hospital characteristics at hospital discharge after acute coronary syndrome were studied. METHODS: Charts of patients with acute coronary syndrome discharged from 13 Dutch hospitals in 2012 were reviewed. Guideline adherence was defined as the prescription of acetylsalicylic acid, P2Y12 receptor inhibitor, statin, beta-blocker and angiotensin-converting enzyme (ACE) inhibitor at discharge, or a documented contraindication. Associated characteristics were identified by means of generalized linear mixed models for binary outcomes. RESULTS: In total, 2471 patients were included. Complete guideline adherence was achieved in 69.1 % of the patients, ranging from 42.1 to 87.0 % between hospitals. The ACE inhibitor was most often missing (21.2 %). Patients with non-ST-segment elevation myocardial infarction or unstable angina, patients with a history of coronary artery bypass grafting or elderly women were less likely to be discharged with the guideline-recommended medication. CONCLUSIONS: Guideline adherence for secondary prevention medication following acute coronary syndrome was substantial; however, variation between hospitals and patient groups was found. Efforts to increase guideline adherence can focus on underperforming hospitals and undertreated patient groups.
No takes yet. Share an insight, caveat, or question.
Tra et al. (2015) conducted a cross-sectional in Acute coronary syndrome (n=2,471). Secondary prevention medication guidelines was evaluated on Complete guideline adherence (prescription of acetylsalicylic acid, P2Y12 receptor inhibitor, statin, beta-blocker, and ACE inhibitor, or documented contraindication). Complete guideline adherence for secondary prevention medication at hospital discharge after acute coronary syndrome was achieved in 69.1% of patients, with lower adherence observed in elderly women and patients with NSTEMI or unstable angina.
Synapse has enriched 10 related papers. Consider them for comparative context: